AVT Stock Analysis: Avnet | NASDAQ
Electronics & Computer Distribution | NASDAQ, USA | Market Cap: 7.243m USD | 12M Return: 85.5% | US0538071038 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 123M
EPS Trend: -67.5%
Qual. Beats: 3
Rev. Trend: -8.3%
Qual. Beats: 5
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Avnet, Inc. (NASDAQ: AVT) is a global distributor of electronic components, operating across the Americas, Europe, the Middle East, Africa, and Asia/Pacific. Founded in 1921 and headquartered in Phoenix, Arizona, the company runs two main segments: Electronic Components and Farnell. It markets and distributes semiconductors, interconnect, passive, and electromechanical components on behalf of manufacturers, while also providing design support, supply chain and logistics services, and embedded solutions including display technologies and custom subsystems. Its end markets span medical, telecommunications, industrial, and digital editing applications, and through Farnell it supplies kits, tools, and test/measurement products directly to engineers and entrepreneurs.
As a Technology Distributor within the Information Technology sector, Avnet operates on a high-volume, low-margin model, acting as an intermediary between component makers and original equipment manufacturers (OEMs) and electronics manufacturing services (EMS) providers. The distributor channel plays a critical role in managing inventory, logistics, and bill-of-materials complexity for customers, with value-added services such as design support and kitting serving as key differentiators in a competitive global market.
- Industrial and automotive demand weakness pressures distribution revenue
- Semiconductor inventory destocking compresses Electronic Components segment margins
- Farnell catalog distribution provides stable offset against cyclical headwinds
| Net Income: 334.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -7.06 > 1.0 |
| NWC/Revenue: 21.10% < 20% (prev 26.53%; Δ -5.43% < -1%) |
| CFO/TA -0.02 > 3% & CFO -280.9m > Net Income 334.4m |
| Net Debt (3.58b) to EBITDA (855.3m): 4.19 < 3 |
| Current Ratio: 1.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (84.7m) vs 12m ago -0.43% < -2% |
| Gross Margin: 10.43% > 18% (prev 10.74%; Δ -0.31% > 0.5%) |
| Asset Turnover: 200.6% > 50% (prev 183.2%; Δ 17.45% > 0%) |
| Interest Coverage Ratio: 2.85 > 6 (EBIT TTM 720.6m / Interest Expense TTM 253.1m) |
| A: 0.38 (Total Current Assets 13.3b - Total Current Liabilities 7.50b) / Total Assets 15.4b |
| B: 0.23 (Retained Earnings 3.51b / Total Assets 15.4b) |
| C: 0.05 (EBIT TTM 720.6m / Avg Total Assets 13.8b) |
| D: 0.48 (Book Value of Equity 5.02b / Total Liabilities 10.4b) |
| Altman-Z'' = 4.08 = AA |
| DSRI: 1.28 (Receivables 6.88b/4.33b, Revenue 27.6b/22.2b) |
| GMI: 1.03 (GM 10.74% / 10.43%) |
| AQI: 0.76 (AQ_t 0.08 / AQ_t-1 0.10) |
| SGI: 1.24 (Revenue 27.6b / 22.2b) |
| TATA: 0.04 (NI 334.4m - CFO -280.9m) / TA 15.4b) |
| Beneish M = -2.73 (Cap -4..+1) = A |
As of October 28, 2026, the stock is trading at USD 92.95 with a total of 770,197 shares traded. Over the past week, the price has changed by +2.08%, over one month by -8.38%, over three months by +5.59% and over the past year by +85.53%.
Current recommended Stop Loss: 88.10 (which is 5.2% or 1.3 ATR below the current price).
Avnet has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold AVT.
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 106.3 | 14.3% |
P/E Trailing = 21.9651
P/E Forward = 7.0972
P/S = 0.2621
P/B = 1.6055
P/EG = 2.6486
Revenue TTM = 27.6b USD
EBIT TTM = 720.6m USD
EBITDA TTM = 855.3m USD
Long Term Debt = 2.48b USD (from longTermDebt, last quarter)
Short Term Debt = 789.8m USD (from shortTermDebt, last quarter)
Debt = 3.74b USD (from shortLongTermDebtTotal, last quarter) + Leases 263.0m
Net Debt = 3.58b USD (calculated: Debt 3.74b - CCE 155.4m)
Enterprise Value = 10.8b USD (7.24b + Debt 3.74b - CCE 155.4m)
Interest Coverage Ratio = 2.85 (Ebit TTM 720.6m / Interest Expense TTM 253.1m)
EV/FCF = -30.54x (Enterprise Value 10.8b / FCF TTM -354.5m)
FCF Yield = -3.27% (FCF TTM -354.5m / Enterprise Value 10.8b)
FCF Margin = -1.28% (FCF TTM -354.5m / Revenue TTM 27.6b)
Net Margin = 1.21% (Net Income TTM 334.4m / Revenue TTM 27.6b)
Gross Margin = 10.43% ((Revenue TTM 27.6b - Cost of Revenue TTM 24.8b) / Revenue TTM)
Gross Margin QoQ = 10.43% (prev 10.38%)
Tobins Q-Ratio = 0.70 (Enterprise Value 10.8b / Total Assets 15.4b)
Interest Expense / Debt = 6.77% (Interest Expense 253.1m / Debt 3.74b)
Taxrate = 28.46% (133.0m / 467.4m)
NOPAT = 515.5m (EBIT 720.6m * (1 - 28.46%))
Current Ratio = 1.78 (Total Current Assets 13.3b / Total Current Liabilities 7.50b)
Debt / Equity = 0.74 (Debt 3.74b / totalStockholderEquity, last quarter 5.02b)
Debt / EBITDA = 4.19 (Net Debt 3.58b / EBITDA 855.3m)
Debt / FCF = -10.11 (negative FCF - burning cash) (Net Debt 3.58b / FCF TTM -354.5m)
Total Stockholder Equity = 4.94b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.43% (Net Income 334.4m / Total Assets 15.4b)
RoE = 6.77% (Net Income TTM 334.4m / Total Stockholder Equity 4.94b)
RoCE = 9.71% (EBIT 720.6m / Capital Employed (Equity 4.94b + L.T.Debt 2.48b))
RoIC = 6.02% (NOPAT 515.5m / Invested Capital 8.56b)
WACC = 8.40% (E(7.24b)/V(11.0b) * Re(10.24%) + D(3.74b)/V(11.0b) * Rd(6.77%) * (1-Tc(0.28)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.72 | Cagr: -3.26%
[DCF] Fair Price = unknown (Cash Flow -354.5m)
EPS Correlation: -67.53 | EPS CAGR: -19.21% | SUE: 4.0 | # QB: 3
Revenue Correlation: -8.34 | Revenue CAGR: -0.67% | SUE: 3.87 | # QB: 5
EPS current Quarter (2026-09-30): EPS=2.86 | Chg30d=+8.77% | Revisions=+50% | Analysts=3
EPS next Quarter (2026-12-31): EPS=2.97 | Chg30d=+8.18% | Revisions=+50% | Analysts=3
EPS current Year (2027-06-30): EPS=11.41 | Chg30d=+7.90% | Revisions=+57% | GrowthEPS=+101.2% | GrowthRev=+34.1%
EPS next Year (2028-06-30): EPS=12.46 | Chg30d=+12.79% | Revisions=+0% | GrowthEPS=+9.2% | GrowthRev=+5.8%
[Analyst] Revisions Ratio: +77% (up=10, down=0)